Results 101 to 110 of about 275,152 (253)

A Case of Palmoplantar Keratodermas Complicated by Pseudoainhum and Literature Review

Clinical, Cosmetic and Investigational Dermatology
Junhong Ye,1 Wen Li,1 Xianxu Yang,1 Yanhai Shi,2 Wen Lv3 1Department of Plastic Surgery and Skin Disease, Hainan Fifth People’s Hospital, Haikou City, Hainan Province, People’s Republic of China; 2Department of Skin Disease, Qionghai People’s Hospital ...
Ye J, Li W, Yang X, Shi Y, Lv W
doaj  

The impact of a preprescribing formative assessment on learning in final‐year medical students using hospital inpatient electronic prescribing systems

British Journal of Clinical Pharmacology, EarlyView.
Aims Graduating medical students consistently report being unprepared for the complexity of prescribing in clinical practice. Current clinical prescribing teaching and authentic assessment are limited due to patient safety concerns. We aimed to examine the educational utility of supervised preprescribing as a learning process and potential authentic ...
Kellie A. Charles, Lorna Pairman, Emily Moon, Daniel Wong, John Quayle, Tim J. Wilkinson, Matthew Doogue, Paul Chin   +7 more
wiley   +1 more source

Investigating the Impact of Circulating Immune Cells on Acne Using Mendelian Randomization

Clinical, Cosmetic and Investigational Dermatology
Xudong Wang,1,2,* Shaoyu Guan,3,* Zhikuan Xia,2 Xin Zhang,2 Yu Bai,2 Qiang Li,4 Haitao Li,2 Rongya Yang2 1Southern Medical District of Chinese PLA General Hospital, Beijing, 100843, People’s Republic of China; 2Department of Dermatology ...
Wang X, Guan S, Xia Z, Zhang X, Bai Y, Li Q, Li H, Yang R   +7 more
doaj  

Clinical Images: Subcutaneous panniculitis‐like T cell lymphoma

Arthritis &Rheumatology, EarlyView.
S Chambers, CN Myrdal, VP Werth
wiley   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

Clinical Features, Treatment Effectiveness and Long-Term Outcomes in Children with Moderate-to-Severe Generalized Pustular Psoriasis: A Retrospective Cohort Study

Journal of Inflammation Research
Zhiqiang Cao,1,* Bin Peng,1,* Zonghao Li,2 Ruiqi Li,1 Ruitao Fan,1 Baibing Mi,2 Bingjie Li,1 Xiangjin Song,1 Jing Shi,1 Songmei Geng1 1Department of Dermatology, Northwest Hospital, The Second Hospital Affiliated of Xi’an Jiaotong ...
Cao Z, Peng B, Li Z, Li R, Fan R, Mi B, Li B, Song X, Shi J, Geng S   +9 more
doaj  

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden, Miriam G. Mooij, Matthijs de Hoog, Saskia N. de Wildt   +3 more
wiley   +1 more source

Analysis of the Efficacy and Safety of Secukinumab Combined with Surgical Treatment for Hidradenitis Suppurativa: A Real-World Retrospective Study in China

Journal of Inflammation Research
Xiaojie Liu,1,* Chuanjian Yuan,2,* Yuan Kang,3,* Jun Zhang,1 Yibo Li,1 Ruiqi Wang,1 Chen Ding,1 Junling Zhang,1,* Weibin Xing1,* 1Department of Dermatology, Affiliated Hospital of Tianjin Academy of Traditional ...
Liu X, Yuan C, Kang Y, Zhang J, Li Y, Wang R, Ding C, Zhang J, Xing W   +8 more
doaj  

Pharmacokinetic‐pharmacodynamic modelling of risankizumab using chronic plaque psoriasis real‐world data

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Risankizumab is a high‐cost biologic treatment for chronic plaque psoriasis, an immune‐mediated inflammatory disease presenting with painful red scaly skin lesions. Inter‐individual heterogeneity in treatment response may be better addressed with personalised rather than fixed dosing. We sought to develop a pharmacokinetic/pharmacodynamic (
Charlotte M. Thomas, Jessica Ruoheng Wei, David Baudry, Zehra Arkir, Bola Coker, Tejus Dasandi, Kingsley Powell, Monica Arenas‐Hernandez, Jenny Leung, Krystal Rawstron, Chioma Nwaogu, Richard Woolf, Andrew E. Pink, Jonathan Barker, Joseph F. Standing, Catherine H. Smith, Satveer K. Mahil   +16 more
wiley   +1 more source

Vol. 24 No. 1 (2026): Nepal Journal of Dermatology, Venereology & Leprology

Nepal Journal of Dermatology, Venereology & Leprology
Table of Content ...
Nepal Journal of Dermatology, Venereology and Leprosy
doaj   +2 more sources